August 13, 2013 — The U.S. Judicial Panel on Multi-District Litigation (JPML) has issued a Transfer Order (PDF) to centralize Brilliant Blue G lawsuits against Franck’s Pharmacy into a Multi-District Litigation (MDL). Brilliant Blue G is an unapproved drug in the United States that was recalled after it was associated with fungal eye infections.
The litigation currently contains 21 lawsuits in six district courts from plaintiffs who were injured by eye infections, blindness, and other injuries caused by contaminated medicines used in eye surgery.
The JPML has centralized in the litigation in the Eastern District of Pennsylvania, where four actions are currently pending before Judge Kurt D. Engelhardt.
Franck’s Pharmacy recalled Brilliant Blue G, Triamcinalone, and Avastin from March until May 2012. The U.S. Food and Drug Administration (FDA) issued recall notifications on March 19, April 20, and May 4, culminating in a recall of all compounded products labeled as sterile from Franck’s.
Eye infections (fungal endophthalmitis) occur when tissue in the eyes becomes inflamed. In severe cases, patients with fungal eye infections may suffer from permanent blindness or loss of vision.
Symptoms of a Brilliant Blue G eye infection include:
- Decreased vision
- Eye pain
- Blurry vision
- Discharge (yellow, green, watery, or bloody)
- Sores on the eye
- Feeling like something is in the eye
Need a Texas Brilliant Blue G Lawyer?
Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.
Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”
The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $60 million in verdicts and/or settlements. Please use the form below to contact our Texas Brilliant Blue G lawyers for a free lawsuit review.